By John Ikani
Benin, Liberia, and Sierra Leone have in a landmark move against malaria, integrated the RTS,S vaccine into their regular vaccination regimens.
Children aged five months and older in these nations will be administered the vaccine in four doses as part of their routine immunization schedule.
Benin has received 215,900 doses of the vaccine, while Liberia and Sierra Leone have been allocated 112,000 and 550,000 doses, respectively.
“The World Health Organization (WHO), Unicef, and the global vaccine alliance (Gavi) are driving this initiative,” stated a joint release.
This initiative represents a significant stride in malaria prevention across Africa, where the disease exerts its greatest toll.
READ ALSO: US Temporarily Withdraws Troops From Chad
In 2022, Africa bore the brunt of the malaria burden, accounting for 94% of all cases and 95% of global malaria-related fatalities, as per WHO data.
The successful deployment of the vaccine has already been witnessed in Cameroon, Burkina Faso, Ghana, Kenya, and Malawi.
Pilot programs conducted in three of the nations resulted in a notable 13% decline in mortality among eligible children who received the vaccine.
Anticipation looms as more African countries gear up to join the RTS,S vaccine rollout in the upcoming months, alongside the anticipated introduction of the R21 vaccine, the second WHO-approved immunization.
Why this matters
The integration of the RTS,S vaccine in West African countries like Benin, Liberia, and Sierra Leone marks a crucial advancement in combating malaria.
The move promises to significantly reduce the disease’s devastating impact in the region, where malaria is a leading cause of illness and death, particularly among children and pregnant women.
By introducing the vaccine, these nations aim to save lives, improve health outcomes, and alleviate the economic burden associated with malaria.
In addition, the initiative contributes to global health security efforts by addressing a disease with widespread implications beyond national borders.
